Health & Wellness The Bone Health Debate: Analyzing the Impact of GLP-1 Agonists on Skeletal Integrity September 3, 2026 Siti Muinah For millions of Americans, the advent of glucagon-like peptide-1 (GLP-1) receptor agonists—marketed under names such as Ozempic, Wegovy, and Zepbound—has fundamentally altered the landscape of metabolic medicine. These injectable therapies,…
